Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798758
Max Phase: Preclinical
Molecular Formula: C52H61ClN3O9P
Molecular Weight: 903.05
Molecule Type: Unknown
Associated Items:
ID: ALA4798758
Max Phase: Preclinical
Molecular Formula: C52H61ClN3O9P
Molecular Weight: 903.05
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H]1c2ccc(NC(=O)CCCCCCCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)c(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Cl-]
Standard InChI: InChI=1S/C52H60N3O9P.ClH/c1-32-36-29-30-37(45(57)40(36)46(58)41-39(32)47(59)43-44(55(2)3)48(60)42(51(53)63)50(62)52(43,64)49(41)61)54-38(56)28-20-9-7-5-4-6-8-10-21-31-65(33-22-14-11-15-23-33,34-24-16-12-17-25-34)35-26-18-13-19-27-35;/h11-19,22-27,29-30,32,39,43-44,47,59,64H,4-10,20-21,28,31H2,1-3H3,(H5-,53,54,56,57,58,60,61,62,63);1H/t32-,39+,43+,44-,47-,52-;/m0./s1
Standard InChI Key: BTRPIKVITBGONZ-RXGBFWRUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 903.05 | Molecular Weight (Monoisotopic): 902.4140 | AlogP: 6.49 | #Rotatable Bonds: 18 |
Polar Surface Area: 210.72 | Molecular Species: ACID | HBA: 10 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 2.87 | CX Basic pKa: 7.78 | CX LogP: 4.35 | CX LogD: 3.85 |
Aromatic Rings: 4 | Heavy Atoms: 65 | QED Weighted: 0.02 | Np Likeness Score: 0.78 |
1. Cochrane EJ,Hulit J,Lagasse FP,Lechertier T,Stevenson B,Tudor C,Trebicka D,Sparey T,Ratcliffe AJ. (2021) Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells., 12 (4.0): [PMID:33859798] [10.1021/acsmedchemlett.0c00632] |
Source(1):